Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)
Clinical trial NCT06880081 · RECRUITING
Trial details
- NCT number
- NCT06880081
- Sponsor
- Chongqing Peg-Bio Biopharm Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-07
- Primary completion
- 2026-02-27
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.